Affinity of Alkylphosphocholines to Biological Membrane of Prostate Cancer: Studies in Natural and Model Systems
Open Access
- 22 May 2014
- journal article
- research article
- Published by Springer Nature in The Journal of Membrane Biology
- Vol. 247 (7) , 581-589
Abstract
The effectiveness of two alkylphosphocholines (APCs), hexadecylphosphocholine (miltefosine) and erucylphosphocholine to combat prostate cancer has been studied in vitro with artificial cancerous membrane, modelled with the Langmuir monolayer technique, and on cell line (Du-145). Studies performed with the Langmuir method indicate that both the investigated drugs have the affinity to the monolayer mimicking prostate cancer membrane (composed of cholesterol:POPC = 0.428) and the drug-membrane interactions are stronger for erucylphosphocholine as compared to hexadecylphosphocholine. Moreover, both studied drugs were found to fluidize the model membrane, which may lead to apoptosis. Indeed, biological studies confirmed that in Du-145 cell line both investigated alkylphosphocholines cause cell death primarily by apoptosis while necrotic cells constitute only a small percentage of APC-treated cells.Keywords
This publication has 41 references indexed in Scilit:
- Interactions of Alkylphosphocholines with Model Membranes—The Langmuir Monolayer StudyThe Journal of Membrane Biology, 2013
- The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiationRadiation Oncology, 2010
- Effects of β-Cyclodextrin on the Structure of Sphingomyelin/Cholesterol Model MembranesBiophysical Journal, 2010
- In Vitro and In Vivo Inhibition of Neuroblastoma Tumor Cell Growth by AKT Inhibitor PerifosineJNCI: Journal of the National Cancer Institute, 2010
- Activation of Membrane Cholesterol by 63 AmphipathsBiochemistry, 2009
- Model membrane systems and their applicationsCurrent Opinion in Chemical Biology, 2007
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- Use of cyclodextrins to manipulate plasma membrane cholesterol content: Evidence, misconceptions and control strategiesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipidInvestigational New Drugs, 2005
- Membrane structural dynamics of plasma membranes of living human prostatic carcinoma cells differing in metastatic potentialExperimental Cell Research, 1991